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The anchoring fibrils at the dermal-epidermal junction have 
been well characterized as ultrastructural entities. From their 
appearance, it was proposed that they fortified the attach-
ment of the epidermis to the dermis. This hypothesized 
function was strengthened by observations indicating that 
the anchoring fibrils were abnormal, diminished, or absent 
from individuals with dystrophic epidermolysis bullosa. 
Therefore, characterization of the molecular constituents of 
the anchoring fibrils and their interactions with other base-
ment membrane and dermal components might lead to iden-
tification of the gene defects underlying at least some forms 
of epidermolysis bullosa. Type VII collagen was identified as 
the protein component of anchoring fibrils in 1986. Since 
then, the major characteristics of the molecule have been 
described. These are consistent with a model wherein se-
creted type VII collagen molecules form disulfide-bond sta-
bilized antiparallel dimers. The dimers then condense later-
T he purpose of this brief review is to summarize the current status of studies of type VII collagen and its function as the anchoring fibril protein. I will try to indicate those aspects of past studies that have with-stood the test of time during the ten years since type 
VII was first reported, and try to make corrections where more 
recent studies contradict past findings. I will also try to point out 
certain aspects of type VII collagen function that are based upon 
correlations or modeling, which mayor may not be correct in detail, 
as well as those that are based upon solid structural information. It 
will be very interesting to observe the modifications of these con-
cepts that will inevitably occur as characterization of the molecular 
defects underlying dystrophic epidermolysis bullosa (DEB) become 
increasingly abundant. 
At this point, as a result of the initial biochemical analyses and 
subsequent primary structure prediction, the structure of the type 
VII molecule is quite well understood. The amino terminus con-
tains the large NC-1 domain [1- 6]. Rotary shadowed images (Fig 
1) of this domain examined by transmission electron microscopy 
appear as three apparently identical extended structures joined by 
disulfide bonds at their C-terminus within a large globule. In some 
micrographs, the N-tennini appear to end in smaller globules, but 
most often the individual arms appear as elongated structures in-
creasing in thickness from the C- to the N-terminus [2]. Biochemi-
cal analysis of the NC-1 domain subunit chains described three 
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ally into unstaggered arrays that are the anchoring fibrils . 
This arrangement allows for the protrusion of large globular 
domains (NC-1) from both ends of the fibrils. The aggre-
gated triple-helical domains extend into the papillary dermis 
and entrap fibrous dermal components. The NC-l domains 
are believed to interact with components of the basement 
membrane and thus to mediate the attachment of the base-
ment membrane to the dermis. This model predicts that mu-
tations in the type VII collagen gene that prevent the secre-
tion of the molecule will be the most devastating, whereas 
mutations in the regions encoding the globular domains may 
show more variable phenotype. Ultimately, understanding 
the function of type VII collagen at the molecular level will 
be the key to devising strategies to moderate the pathophysi-
ology of dystrophic epidermolysis bullosa. ] Invest Dermatol 
101:252-255,1993 
polypeptides of about 150 kDa that could not be separated by any 
applied technology, suggesting that all three subunits were derived 
from the same gene product. This estim.ate compares well with the 
predicted amino acid sequence of the a1(VII) chain, which indicates 
that the domain is a composite of a cartilage matrix protein (CMP) 
homology, followed by nine fibronectin type III (FNIII) repeats and 
a von Willebrand factor (vWF) repeat [5-8] (Fig 2). The sequence 
of the complete amino terminus is not yet published. The data 
suggest that the C-terminallarge globule of NC-1 joining the indi-
vidual arms is contributed by the second vWF repeat, while the 
extension of the arms results from the series of FNIII repeats. The 
CMP repeat may coincide with the N-terminal globule sometimes 
observed by rotary shadowing. 
We originally assigned the NC-1 domain to the C-terminus of 
the a1(VII) chain [3]. This was based upon a comparison of the 
amino acid sequence determined for the intact triple-helical domain 
with the sequence of the P1 pepsin fragment, which was identified 
by electron microscopy to be involved in dimer formation. These 
peptides both produced the same sequence, indicating that the P1 
fragment was at the amino terminus of the triple-helical domain and 
therefore P2, which was adjacent to the NC-1 domain, must be at 
the C-terrninus. Predictions of amino acid sequence from analysis of 
the cDNA of a1 (VII) [7] has proved this to be incorrect. Presum-
ably, the sequence ofP1 we reported actually derived from contam-
inating P2 pep tides that produced the dominant sequence signal 
because the N-terminus ofp1 was probably blocked by spontaneous 
cyclization. The occurrence of NC-1 at the amino terminus is far 
more consistent with the structures of other collagen types. The 
large non-triple-helical domains of types IV, XII, and XIV colla-
gens occur at the amino terminus. It is also consistent with the 
generally accepted concept that the triple-helical domain of colla-
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Figure 1. Rotary shadowed image of the type VII molecule synthesized and 
secreted from human keratinocytes in culture. The image shows the 424-
run -long triple helical domain and the tow terminal globular domains. The 
amino-terminal NC-l domain is particularly large with each subunit a chain 
contributing the structure of an extended arm. The NC-2 domain is consid-
erabl y smaller and appears as a single globule. Micrograph courtesy of 
Douglas Keene, Shriners Hospital for Crippled Children, Portland, Oregon. 
gens fold intracellularly from .the C-terminus. It has always bee.n 
difficult to reconCIle the foldtng of type VII collagen WIth tillS 
mechanism when it was believed that the independently folded 
arms of the NC-1 domain somehow nucleated triple-helix assem-
bly . 
The triple-helical domain of a1(VII) is unusually long (424 nm, 
170 kDa) and flexible [1 ,9]. The flexibility of the domain is due to 
the presence of a large discontinuity in the triple-helical structure at 
the junction of the major pepsin fragments P1 and P2. Shorter 
disruption of the Gly-X-Y motif specifying helical structure occur 
throughout the length of the domain. 
The C-terrninal NC-2 domain forms a small globule visualized 
by rotary shadowing [10] (Fig 1). Biochemical estimates of the 
molecular mass of this domain predicted masses of 32 and 34 kDa. 
This is in considerable excess of the cDNA prediction. The reason 
for this discrepancy may eventually be explained by post-transla-
tional glycosylation (which has yet to be characterized), or by sec-
ondary structures that are resistant to sodium dodecylsulfate dena-
turation and hold the polypeptide in an extended conformation, 
slowing its migration through electrophoretic gels. 
It is assumed that the type VII collagen molecule is composed of a 
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Figure 2_ The domain structure of type VII collagen predicted from cDNA 
sequencing. The diagram indicates the relative positions of the CMP, type 
III fibronectin , and vWF homologies within NC-1. As shown, nearly one 
half of the transcript encodes non-triple-helical structure. The positions of 
cysteinyl residues are indicated (c) in clusters towards the C-terrrunus where 
the are likely to stabilize the type VII dimers. Additional cysteine clusters 
occur at the NC-l - triple helical junction. These stabilize the structure of 
the central globule of NC-1. The illustration is courtesy of Drs. Angela 
Christiano and Jouni Vitto, Jefferson Medical School, Philadelphia, Penn-
sylvania. 
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Figure 3_ Hypothetical model for the assembly of anchoring fibrils from 
type VII collagen. Type VII collagen is secreted as a monomer. Monomers 
then dimerizc by a 60-nm overlap of the C-terminal ends. The stagger of the 
ovedap is believed to be specified by an interaction of NC-2 with a specific 
re~lOn of the tnple heltx. The .overlap allows alignment of opposing cysteine 
reSidues, whIch then form disulfide bonds that stabilize the dimer. After 
disulfide bond formation. the NC-2 domains are proteolytically removed. 
The dllners then condense 111 an unstaggered lateral array as anchoring 
fibrils. 
single gene product, al(VII). This prediction derives from the fail-
ure of biochemical methods to fractionate the whole type VII chains 
or the P1 and P2 peptides into more than one chromatograrhic or 
e1ectrophore.tic fraction. This is supported by the finding 0 single 
mRNA species cncodlllg type VII -like sequences [7]- Further sup-
port derives from the mapping of all DEB mutations to the same 
genomic region [11 - 15]. However, there are several observations 
that urge caution in fully accepting this conclusion. Attempts to 
characterize the NC-2 domain always showed two species: one with 
an electrophoretic migration consistent with a mass of 32 kDa, 
another with a predicted mass of 34 kDa. This heterogeneity has 
never been understood. Secondly, protein sequencing of CNBr 
fragments of the triple-helical domain by Dr. Ivan Rocos, and of 
NC-1 by Dr. Louise Rosenbaum when the work was done in Port-
land, identified a number of peptide sequences that have not been 
found in the reported cDNA predictions. The percentage of uni-
dentified sequences t~ sequences'p'l~ced within al(VII) is signifi-
cant, and consistent With the pOSSlblltty that another type VII chain 
may exist. The DEB linkage studies do not rule out this possibility if 
a second type VII gene is closely linked to COL7A1. Alternatively, 
these observations could have trivial explanations. In any case, those 
directly working with type VII collagen might bear this possibility 
in mind. 
a 1 (VII) is synthesized by keratinocytes [2,4,16- 22] and to a lesser 
extent by dermal mesenchymal cells [4,20].171 vitro, the mesenchy-
mal contribution is incorporated into the basement membrane made 
by dermal equivalents (Marinkovich, Nishiyama, and Burgeson, 
unpublished observations). After secretion, the type VII molecules 
dimerize [3] (Fig 3). Subsequently, the dimers become disulfide 
bonded, but this crosslink is not made in cel l culture under standard 
conditions, even though non-covalently stabilized dimers are ob-
served i71 vitro. We have assumed that dimerization is catalyzed by 
binding of the NC-2 domain to a specific region of the triple-helix. 
This assumption is based upon the observation that the dimers 
formed i71 vitro retain the NC-2 domains on the C-terminii of the 
molecules; therefore it is not necessary that NC-2 be removed to 
obtain dimer formation . Also, we have never been able to form 
dimers i71 vitro from isolated triple-helical domains or from P1 
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Figure 4. Drawing of the proposed anchoring fibril network. As shown, 
anchoring fibrils originate within the lamina densa and extend perpendicu-
larly into the upper regions of the papillary dermis where they condense 
with the ends of other anchoring fibrils and with ubiquitous basement 
membrane components to form anchoring plaques. Additional anchoring 
fibrils bridges these plaques with plaques deeper in the papillary dermis. The 
extended network thus formed is capable of entrapping large numbers of 
dermal fibrous elements, thereby securing the lamina densa to the dermis. 
fragments. Based upon this assumption it is logical to predict that 
mutations in NC-2 or in the region of triple-helix about 60 nm 
N-terminal to NC-2 could prevent dimer formation, resulting in a 
non-functional anchoring fibril network. It will be very interesting 
to see if this prediction holds. 
The anchoring fibril network (Fig 4) has been described as pri-
mary fibrils originating in the lamiria densa of the basement mem-
brane..'looping into the, upper' regions of the papillary dermis and 
reinserting into the lamina densa. The loops surround and entrap 
the fibrous dermal elements, securing the basement membrane to 
the dermis. We described a secondary network [23,24] in which 
anchoring fibrils originating in the lamina densa extend perpendic-
ularly into the dermis and insert into amorphous elements contain-
ing type IV collagen and probably laminin, and perhaps other ubiq-
uitous basement membrane components. We called these structures 
anchoring plaques. The acceptance of these structures has been con-
troversial; however, none of our subsequent experience with ultra-
structural visualization of the upper papillary de'rmis contradicts this 
original conclusion. A ~imilar arrangement of these molecules has 
been reported in corncil [25]' , 
The formation of the anchoring fibril network requires the NC-l 
domain to interact with constituents of the lamina densa and the 
anchoring plaques. Solid-phase binding studies indicated that iso-
lated NC-l could bind type IV collagen and laminin [26] (and 
kalinin/K-Iaminin; Burgeson, unpublished), suggesting that the as-
sembly and stability of the anchoring fibril network is dependent 
upon the interactions of basement membrane components with 
N C-l . The molecular mechanisms of these potential interactions 
have not been further characterized. Potential interactions of the 
NC-l domains with keratinocyte basal surface transmembrane pro-
teins has never been documented. With the identification of the 
cDNA encoding NC-l the possibility of further dissecting the 
binding functions of the CMP, vWF, and FNIII sub domains using 
recombinant fragments exists. Although difficult to perform, and 
even more difficult to interpret unambiguously, such studies would 
greatly facilitate the interpretation of molecular defects that are 
certain to be found in the region of the gene encoding NC-1. From 
the lessons learned [27] from the studies of defects underlying os-
teogenesis imperfecta, the Ehiers-Danios syndromes, and the chon-
drodystrophies, it is likely that the most severe forms of dystrophic 
epidermolysis bullosa will result from gene defects that prevent 
accumulation of type VII molecules in the basement membrane 
zone, predominantly by predisposing the molecule to intracellular 
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degradation. However, mutations that interrupt the binding capaci-
ties of the NC-l subdomains are also likely, and these might result 
in some of the more mild forms of the disease. Hybrid mutant/ 
wild-type molecules could exist, exhibiting partial ligand binding 
due to the predicted trivalency of N C-1. 
The predicted relationship of type VII collagen to DEB is now 
well documented. The absence of anchoring fibrils from the base-
ment membrane zone of patients with severe generalized recessive 
epidermolysis bullosa has been a characteristic of the disease. Lack of 
type VII collagen correlates with the same condition [17,21,28_ 
34]. Type VII has also been identified intracellularly within kerati-
nocytes in some patients [16,21], suggesting that a mutation may 
prevent secretion. COL7Al has now been localized to the human 
gene locus 3p21.3 [7,35,36]. Use of observed polymorphisms [35] 
has allowed the demonstration oflinkage of dominant and recessive 
epidermolys~s bullosa t~ the tyfe VII gene [11-15]. The consist-
ency of the hnkage studies of al forms of DEB to type COL7 Al is 
surprising. It has been generally predicted that some of the defects 
resulting in anchoring fibril defects would be secondary to other 
gene defects. The possibility that anchoring fibrils were degraded 
due to aberrant synthesis or activation of collagenase or another 
protease is a particularly attractive possibility [37]. The type VII 
molecule has been shown to be a potential substrate for a variety of 
degradative enzymes [38]. The linkage studies also suggest that type 
VII is the only component of the anchoring fibril. This is very 
unexpected. Although the banding pattern of the segment long 
spacing fibers made from type VII collagen triple-helical domain do 
account for most, if not all, of the centrosymmetric banding seen in 
anchoring fibrils, and type VII is the major structural component of 
the fibrils, there are indications that other molecules may be present 
in the structures. The antigens recognized by the monoclonal anti-
bodies AF-l and AF-2 [39] are prime candidates. The epitopes rec-
ognized by these antibodies have been localized to the anchoring 
fibrils, but have not been found within the type VII molecule. This 
discrepancy remains a mystery, and the AF-l and AF-2 antigens 
have not been further characterized. However, the possibility that 
additional components contribute to anchoring fibril structure and 
function remains. 
The linkage studies firmly tie type VII collagen defects to the 
dystrophic phenotype. Further support for this close association 
derives for studies of the acquired form of DEB. The autoantibodies 
characteristic of this condition specifically recognize the NC-l do-
main of the type VII molecule [40-44]. The autoimmunity appears 
to be associated with the class II HLA allele [45]. 
Very recently, the first mutation in CO L7 A 1 has been identified 
as the cause of recessive DEB within one kindred [46]. The single 
base transmutation encodes a methionine to lysine substitution, near 
the NC-2-triple-helixjunction. The mutation lies within a highly 
conserved region containing cysteine residues that are likely to be 
involved in the process of type VII dimerization. 
Preparatioll oJthis review was sigl'l!Jicalltly aided by Ms, Cilldy Clatterbllck and Mr. 
Martill McDo,lOugh, I gratefully ackrlOwledge tile cOlltributions oj Drs, Allgela 
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